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Copyright © 200? JCBN Summary Previously,  we  identified  four  metabolites  of  (−)-epicatechin  in  blood  and
urine: (−)-epicatechin-3'-O-glucuronide (E3'G), 4'-O-methyl-(−)-epicatechin-3'-O-glucuronide
(4'ME3'G), (−)-epicatechin-7-O-glucuronide (E7G), and 3'-O-methyl-(−)-epicatechin-7-O-
glucuronide (3'ME7G) (Natsume et al. Free Radical Biol. Med. 34, 840-849, 2003). The aim of
the current study was to compare the antioxidative activities of these metabolites with that of
their parent compound. After oral administration of (−)-epicatechin, E3'G and 4'ME3'G were
isolated from human urine, and E7G and 3'ME7G isolated from rat urine. We found that
these compounds inhibited peroxynitrite-mediated tyrosine nitration, in the following order of
potency: E3'G > (−)-epicatechin > E7G = 3'ME7G. = 4'ME3'G. These results demonstrate that
the metabolites of (−)-epicatechin retain antioxidative activity on peroxynitrite-induced oxida-
tive damages to some extent.
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Introduction
Catechins are found in high levels in a variety of foods, in-
cluding black tea, apples, wine, and chocolate [1, 2]. Fla-
vonoids including (−)-epicatechin have multiple biological
functions that are thought to reduce the incidence of athero-
sclerosis [3]. Epidemiological studies have suggested that
the intake of catechins correlates with risk reduction for cor-
onary heart disease [4, 5]. (−)-Epicatechin has been shown to
protect biological molecules from nitration by peroxynitrite
[6]. Oxidation of tyrosine residues, which occurs upon the
nitration of proteins, is of particular interest in the pathology
of inflammation. Upon oral administration, most flavonoids
are metabolized in the gastrointestinal tract and absorbed
into the blood. There have been a few reports to date on an-
tioxidant activities in these metabolites [7–9]. We have
shown in humans and rats that, following the ingestion of
cocoa powder, (−)-epicatechin is absorbed from the intes-
tinal tract and distributed as a variety of conjugated and me-
thylated forms in the blood before being excreted in the
urine [10, 11]. We also isolated and identified (−)-epica-
techin glucuronide metabolites from human and rat plasma.
In humans, these include (−)-epicatechin-3'-O-glucuronide
(E3'G) and 4'-O-methyl-(−)-epicatechin-3'-O-glucuronide
(4'ME3'G), and in rat, the metabolites were (−)-epicatechin-
7-O-glucuronide (E7G) and 3'-O-methyl-(−)-epicatechin-7-
O-glucuronide (3'ME7G) [12]. The structures of these com-
pounds are shown in Fig. 1.
The aim of the current study was to examine the antioxi-
dative activities, especially that of nitrotyrosine formation,
of the glucuronide metabolites of (−)-epicatechin present in
human and rat plasma.Inhibitory Effects of Conjugated Epicatechin Metabolites
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Materials and Methods
Peroxynitrite was synthesized from sodium nitrite and
H2O2 using a quenched-flow reactor [13]. H2O2 was elimi-
nated by passage of the peroxynitrite solution over MnO2
powder with the final peroxynitrite concentration deter-
mined by its absorbance at 302 nm (ε =1 6 2 0M −1cm−1).
Protection against peroxynitrite-mediated tyrosine nitration
was performed as described by Arteel et al. [14]. Briefly,
peroxynitrite (0.5 mM) was added as a bolus to a 0.1 mM
tyrosine solution in 0.1 M phosphate buffer (pH 7.3) con-
taining 0.1 mM DTPA with constant vortexing. The effects
of the tested compounds (0–31.5 µM) were determined by
injection of 10 µl of sample, supplemented with 0.1 mM 3-
hydroxy-4-nitrobenzoic acid as an internal standard, onto a
C-18 reverse-phase column (ODS-UG-Deverosil 4.6 × 150
mm; Nomura Chemical, Aichi, Japan) interfaced with the
autosampler from an HP1100 liquid chromatography system
(Agilent Technologies, Palo Alto, CA). Separation was per-
formed with a 50 mM potassium phosphate buffer (pH 7.0)/
acetonitrile step-gradient delivered by the HP1100 system at
a flow rate of 1.0 ml/min. The gradient was initiated at a
ratio of 95:5 buffer/acetonitrile, followed in stepwise adjust-
ment to a final ratio of 50:50 buffer/acetonitrile over 5 min,
with a return to 95:5 buffer/acetonitrile ratio at 13 min,
which was then maintained for an additional 13 min. Forma-
tion of 3-nitrotyrosine was monitored with a UV/visible de-
tector set at 430 nm. To determine the concentration of 3-ni-
trotyrosine in the sample, the peak area ratio of the 3-nitro-
tyosine to the internal standard was calculated and compared
to a standard curve. Each analysis was performed in dupli-
cate.
Results
Figure 2 shows the ability of the test compounds to protect
free tyrosine from the nitration by peroxynitrite. The con-
centration of metabolites required to yield a 50% inhibition
of tyrosine nitration increased in the following order:
E3'G > (−)-epicatechin > E7G = 3'ME7G. = 4'ME3'G.
Discussion
A variety of foods, particularly green tea, chocolate,
cocoa, and red wine have high levels of the flavonoid (−)-
epicatechin [1]. Flavonoids have multiple biological func-
tions, including the suppression of LDL oxidation [3, 15], a
process thought to reduce the incidence of atherosclerosis
[16, 17]. In the present study, we compared the peroxynitrite
scavenging activities of (−)-epicatechin and its four major
metabolites: E3'G and 4'ME3'G, which are found in human
plasma, and E7G and 3'ME7G, which are found in rat plasma
[12]. Peroxynitrite may be generated in vivo under patholog-
ical conditions, especially in the inflammatory response, due
to the reaction of superoxide radicals with nitric oxide. Per-
oxynitrite causes injury and degeneration of endothelial cells
and erythrocytes [18]. Moreover, (−)-epicatechin strongly
suppresses nitration of tyrosine residues of LDL by Myelo-
peroxidase (MPO)/nitrite or peroxynitrite [19]. Flavonoids
protect biological molecules against peroxynitrite-mediated
nitration by neutralizing peroxynitrite and its reaction inter-
mediate, the tyrosyl radical [6, 20–24]. In this study, we
Fig. 1. Structures of (−)-epicatechin and its glucuronide metab-
olites isolated from human and rat urine. (a) (−)-
epicatechin. (b) (−)-epicatechin-3'-O-glucuronide (E3'G).
(c) 4'-O-mehyl-(−)-epicatechin-3'-O-glucuronide (4'ME3'G).
(d) (−)-epicatechin-7-O-glucuornide (E7G), and (e) 3'-
O-methyl-(−)-epicatechin-7-O-glucuonide (3'ME7G).
Fig. 2. Protective effect by (−)-epicatechin and its metabolites
against nitration of tyrosine residues by peroxynitrite
(−)-epicatechin (closed circles), E3'G (open triangles),
4'ME3'G (open squares), E7G (closed triangles) and
3'ME7G (closed squares). Each analysis was performed
in duplicate.M. Natsume et al.
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found that both (−)-epicatechin and its metabolites inhibited
peroxynitrite-mediated nitration. E3'G was more potent than
(−)-epicatechin and the other metabolites at the concentra-
tions between 2.1 and 42.8 µM. (−)-Epicatechin glucuronide
and methylated forms of epicatechin were similar in their
ability to inhibit tyrosine nitration. In the presence of
0.5 mM peroxynitrite, the IC50 values of (−)-epicatechin
and E3'G were 32.1 and 21.6 µM, as calculated by linear re-
gression analyses, respectively. Wipple et al. [6] reported
that one equivalent of (−)-epicatechin prevents nitration by
15–30 equivalents of peroxynitrite.
An alternative action mechanism for epicatechin was pro-
posed by Schroeder et al. [21], who hypothesized that epi-
catechin acts at the interference with tyrosyl radicals rather
than by direct interaction with peroxynitrite. Furthermore,
the plasma metabolites of epicatechin may contribute to the
antioxidant activity on peroxynitrite attack in blood plasma
after administration of catechin rich foods.
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